Serial #90559876
DEAD

Serial Number

90559876

Owner

Nuvo Pharmaceuticals Inc.

Attorney

Gary P. Oakeson

Filing Date

Mar 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90559876 Trademark

Serial Number: 90559876

Serial #90559876 is a trademark filed by Nuvo Pharmaceuticals Inc. on March 4, 2021. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Nuvo Pharmaceuticals Inc. (4 trademarks)

Suite 610
Mississauga, ON L5N6J5 , CA

Entity Type: 03

Trademark Details

Filing Date

March 4, 2021

Registration Date

Not Registered

Goods & Services

Custom manufacturing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; custom manufacturing of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations

Operation of a commercial health care business, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, developing of marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, developing marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Operation of a commercial health care business, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, distributorship services in the field of non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, distributorship services in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations

Licensing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Licensing of health care products, namely, non-medicated and non-prescription products used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations

Research, development and design of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; research, development and design of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 30, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 30, 2024 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 6, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 6, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 6, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 14, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 24, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 24, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 24, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 3, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 7, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 7, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 7, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 27, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 27, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 27, 2022 CNSL
EXAMINER'S AMENDMENT ENTERED
May 3, 2022 XAEC
ASSIGNED TO LIE
May 3, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2022 CNEA
ASSIGNED TO EXAMINER
Apr 4, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 4, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2021 NWOS
NEW APPLICATION ENTERED
Mar 8, 2021 NWAP